tiprankstipranks
Trending News
More News >
MBX Biosciences, Inc. (MBX)
NASDAQ:MBX
US Market

MBX Biosciences, Inc. (MBX) Stock Statistics & Valuation Metrics

Compare
36 Followers

Total Valuation

MBX Biosciences, Inc. has a market cap or net worth of $380.04M. The enterprise value is ―.
Market Cap$380.04M
Enterprise Value

Share Statistics

MBX Biosciences, Inc. has 33,424,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,424,370
Owned by Insiders
Owned by Institutions

Financial Efficiency

MBX Biosciences, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -26.48%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-26.48%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee0.00
Profits Per Employee-1.44M
Employee Count43
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of MBX Biosciences, Inc. is -9.94. MBX Biosciences, Inc.’s PEG ratio is 0.46.
PE Ratio-9.94
PS Ratio0.00
PB Ratio1.44
Price to Fair Value2.39
Price to FCF-6.68
Price to Operating Cash Flow-6.78
PEG Ratio0.46

Income Statement

In the last 12 months, MBX Biosciences, Inc. had revenue of 0.00 and earned -61.92M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-68.19M
Pretax Income-61.92M
Net Income-61.92M
EBITDA-67.95M
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was -30.70M and capital expenditures -149.00K, giving a free cash flow of -30.85M billion.
Operating Cash Flow-30.70M
Free Cash Flow-30.85M
Free Cash Flow per Share-0.92

Dividends & Yields

MBX Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.09
52-Week Price Change-47.53%
50-Day Moving Average9.93
200-Day Moving Average
Relative Strength Index (RSI)47.95
Average Volume (3m)241.98K

Important Dates

MBX Biosciences, Inc. upcoming earnings date is May 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 17, 2025
Next Earnings DateMay 12, 2025
Ex-Dividend Date

Financial Position

MBX Biosciences, Inc. as a current ratio of 24.19, with Debt / Equity ratio of 0.07%
Current Ratio24.19
Quick Ratio24.19
Debt to Market Cap0.00
Net Debt to EBITDA0.72
Interest Coverage Ratio0.00

Taxes

In the past 12 months, MBX Biosciences, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

MBX Biosciences, Inc. EV to EBITDA ratio is -8.33, with an EV/FCF ratio of -10.19.
EV to Sales0.00
EV to EBITDA-8.33
EV to Free Cash Flow-10.19
EV to Operating Cash Flow-10.36

Balance Sheet

MBX Biosciences, Inc. has $262.15M in cash and marketable securities with $171.00K in debt, giving a net cash position of -$261.98M billion.
Cash & Marketable Securities$262.15M
Total Debt$171.00K
Net Cash-$261.98M
Net Cash Per Share-$7.84
Tangible Book Value Per Share$7.71

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for MBX Biosciences, Inc. is $39.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$39.00
Price Target Upside243.01% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score6
AI Score38
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis